About the Cancer Drug Resistance Session
Overcoming drug resistance in cancer treatment stands as a paramount challenge in the realm of oncology research, hindering the efficacy of numerous therapeutic avenues. Tumors exhibit resilience through diverse mechanisms, encompassing genetic alterations, alternative pathway activation, and interactions within the tumor microenvironment. Unlocking the complexities of drug resistance is pivotal for fostering novel treatment modalities. Researchers are actively exploring synergistic drug combinations, immunotherapeutic interventions, and precision-targeted therapies to surmount resistance barriers and enhance patient outcomes. Furthermore, breakthroughs in genomic profiling and single-cell analysis are unraveling intricate resistance mechanisms, propelling the development of personalized therapeutic regimens tailored to individual molecular signatures. Confronting cancer drug resistance head-on is indispensable for ushering in a new era of more potent and enduring cancer treatments.
Topics Covered in Cancer Drug Resistance
Acquired Target Mutations
Bypass Pathway Activation
Drug Efflux Pumps
Lineage Plasticity
Drug-Tolerant Persisters
Rational Combinations
Related Scientific Sessions at CIOC 2027
Why Attend the Cancer Drug Resistance Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cancer Drug Resistance work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cancer Drug Resistance research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cancer Drug Resistance track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cancer Drug Resistance Conference 2027 — FAQs
What is the Cancer Drug Resistance track at CIOC 2027?
The Cancer Drug Resistance track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cancer Drug Resistance. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cancer Drug Resistance sessions?
Cancer researchers and clinicians, educators and students with an interest in Cancer Drug Resistance are all welcome — whether presenting or attending.
Can I present my research in the Cancer Drug Resistance track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cancer Drug Resistance sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cancer Drug Resistance track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.